| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |